• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TROPONIN I ES REAGENT PACK; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TROPONIN I ES REAGENT PACK; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 6802301
Device Problems High Readings (2459); Low Readings (2460)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/08/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that non-reproducible, higher and lower than expected vitros tropi es (troponin i es) results were obtained from patient samples from five different patients when tested on a vitros 5600 integrated system.The assignable cause could not be determined.Within run precision testing for instrument 56001580 was within expectations, indicating the instrument was performing as expected.There was no pre-service precision performed for instrument 56001583.Service actions were completed by an ortho field engineer including refurbishing the incubator, performing adjustments, and replacing the cooler.Post service precision testing was within expectations.The service actions returned the instrument to expected operation.An instrument related issue cannot be ruled out as a contributing factor.The customer is not following the sample collection device manufacture¿s recommendation for sample centrifugation, therefore, improper pre-analytical sample handling cannot be ruled out as a contributing factor to the event.It is possible that cellular debris was present in the affected samples, although, this could not be confirmed.The historical tropi es quality control performance is within expectations for both instruments.The level 1 control does not adequately evaluate performance of the vitros tropi es reagent for a sample with troponin i concentrations < url (0.034 ng/ml).A vitros tropi es reagent issue cannot be entirely ruled out as a contributing factor.In addition, ongoing tracking and trending of complaints has not identified any signals that would suggest there is a systemic issue with vitros trop i es reagent lot 3220.
 
Event Description
A customer obtained non-reproducible, higher and lower than expected vitros tropi es (troponin i es) results from patient samples from five different patients when tested on a vitros 5600 integrated system.Patient 1 trop i es result of 0.019 ng/ml vs.The expected result of 0.057 ng/ml, patient 2 trop i es result of 0.045 ng/ml vs.The expected result of <0.012 ng/ml, patient 3 trop i es result of 0.186 ng/ml vs.The expected result of <0.012, 0.017 ng/ml, patient 4 trop i es result of 0.188 ng/ml vs.The expected result of <0.012, <0.012, <0.012 ng/ml, patient 5 trop i es result of <0.012 ng/ml vs.The expected result of 0.409, 0.404, 0.392 ng/ml.Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected.The non-reproducible, higher and lower than expected vitros tropi es patient sample results were reported from the laboratory.Although the result for patient 2 does not meet vitros tropi es numeric potential health and safety criteria, there was treatment based on the higher than expected result.The patient was placed on a heparin drip.It is not known if the treatment was based solely on the higher than expected tropi es result.Per consultation with an ortho medical safety officer, patients on iv heparin are normally under close observation and monitoring for bleeding.If the patient did not experience any serious side effect during the hospital stay, serious long term health risk is unlikely.The customer reported changes in treatment for patient 3 and patient 4 based on the unexpected results.The specifics of these changes in treatment were not provided.It is not known if the treatment was based solely on the unexpected tropi es results.Ortho has not been made aware of any allegation of actual patient harm as a result of this event.This report is number one of three mdr¿s for this event.Three 3500a forms are being submitted for this event as three devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho).Complaint numbers: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TROPONIN I ES REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key8579842
MDR Text Key203706044
Report Number3007111389-2019-00078
Device Sequence Number1
Product Code MMI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 05/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/05/2019
Device Catalogue Number6802301
Device Lot Number3220
Was Device Available for Evaluation? Yes
Date Manufacturer Received04/08/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/08/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-